Dow Down 1.40% Nasdaq Down 1.59%

Myriad Genetics Inc. (MYGN)

-NasdaqGS
38.30 0.27(0.70%) Oct 1, 4:00PM EDT
Prev Close:38.57
Open:38.65
Bid:34.81 x 100
Ask:38.50 x 100
1y Target Est:39.08
Beta:0.93
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:37.51 - 38.83
52wk Range:20.02 - 42.50
Volume:500,764
Avg Vol (3m):724,875
Market Cap:2.79B
P/E (ttm):17.02
EPS (ttm):2.25
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
MYGNDown 0.70%2.79B
ABT61.92B

Key Statistics

Forward P/E (1 yr):17.25
P/S (ttm):3.61
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-15) :1.93
Quarterly EPS Est (Sep-14) :0.41
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):1.29

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Myriad Genetics, Inc., a molecular diagnostic company, focuses on the development and marketing of predictive, personalized, and prognostic medicine tests in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback